Is Tumor-Free Distance an Independent Prognostic Factor for Early-Stage Endometrioid Endometrial Cancer?
Table 2
Surgicopathologic characteristics of patients.
Mean (range)
Age at diagnosis
61.5 years (40–85)
MT
20 mm (8–40)
DOI
14 mm (5–32)
TFD
6 mm (1–17)
TD
35 mm (15–65)
%MI
70% (50–95)
Follow-up time
95.1 months (10–214)
Recurrence time
37.6 months (9–84)
n (%)
FIGO grade
1
6 (4.5%)
2
97 (72.9%)
3
30 (22.6%)
Cytology
Positive
1 (0.8%)
Negative
132 (99.2%)
LVSI
Present
66 (49.6%)
Absent
67 (50.4%)
Recurrence
Yes
9 (6.8%)
No
124 (93.2%)
Death
Yes
2 (1.5%)
No
131 (98.5)
MT: myometrial thickness; DOI: depth of invasion; TFD: tumor-free distance; TD: tumor diameter; %MI: percentage of myometrial invasion; LVSI: lymphovascular space invasion; FIGO: International Federation of Gynecology and Obstetrics.
